Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Addus Homecare ( (ADUS) ) is now available.
At the 2025 annual meeting held on June 18, Addus HomeCare Corporation’s stockholders voted on several key issues. They elected three directors for terms expiring in 2028, ratified PricewaterhouseCoopers LLP as the independent auditor for 2025, and approved executive compensation policies. The board also decided to hold an annual advisory vote on executive compensation, reflecting stockholder preferences.
The most recent analyst rating on (ADUS) stock is a Buy with a $147.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.
Spark’s Take on ADUS Stock
According to Spark, TipRanks’ AI Analyst, ADUS is a Outperform.
Addus HomeCare’s strong financial performance and positive earnings call are the most significant factors contributing to the stock’s score. While the technical analysis suggests stability, the valuation indicates moderate pricing. Challenges in staffing and Medicaid redetermination are noted risks, but the company’s strategic growth and debt reduction efforts provide a positive outlook.
To see Spark’s full report on ADUS stock, click here.
More about Addus Homecare
Addus HomeCare Corporation operates in the healthcare industry, primarily providing home care services. The company focuses on delivering personalized healthcare solutions to individuals in their homes, catering to a growing market demand for in-home care services.
Average Trading Volume: 195,886
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.09B
See more insights into ADUS stock on TipRanks’ Stock Analysis page.